|
1
|
Zoumpourlis V, Goulielmaki M, Rizos E,
Baliou S and Spandidos DA: [Comment] The COVID-19 pandemic as a
scientific and social challenge in the 21st century. Mol Med Rep.
22:3035–3048. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tsamakis K, Tsiptsios D, Ouranidis A,
Mueller C, Schizas D, Terniotis C, Nikolakakis N, Tyros G,
Kympouropoulos S, Lazaris A, et al: COVID-19 and its consequences
on mental health (Review). Exp Ther Med. 21(244)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tsamakis K, Triantafyllis AS, Tsiptsios D,
Spartalis E, Mueller C, Tsamakis C, Chaidou S, Spandidos DA, Fotis
L, Economou M and Rizos E: COVID-19 related stress exacerbates
common physical and mental pathologies and affects treatment
(Review). Exp Ther Med. 20:159–162. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Efstathiou V, Stefanou MI, Siafakas N,
Makris M, Tsivgoulis G, Zoumpourlis V, Spandidos DA, Smyrnis N and
Rizos E: Suicidality and COVID-19: Suicidal ideation, suicidal
behaviors and completed suicides amidst the COVID-19 pandemic
(Review). Exp Ther Med. 23(107)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Giannopoulou I, Galinaki S, Kollintza E,
Adamaki M, Kympouropoulos S, Alevyzakis E, Tsamakis K, Tsangaris I,
Spandidos DA, Siafakas N, et al: COVID-19 and post-traumatic stress
disorder: The perfect ‘storm’ for mental health (Review). Exp Ther
Med. 22(1162)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Centers for Disease Control and Prevention
(CDC): Post-COVID conditions: Information for healthcare providers,
2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.
|
|
7
|
Deer RR, Rock MA, Vasilevsky N, Carmody L,
Rando H, Anzalone AJ, Basson MD, Bennett TD, Bergquist T, Boudreau
EA, et al: Characterizing long COVID: Deep phenotype of a complex
condition. EBioMedicine. 74(103722)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Brodin P: Immune determinants of COVID-19
disease presentation and severity. Nat Med. 27:28–33.
2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Stefanou MI, Palaiodimou L, Bakola E,
Smyrnis N, Papadopoulou M, Paraskevas GP, Rizos E, Boutati E,
Grigoriadis N, Krogias C, et al: Neurological manifestations of
long-COVID syndrome: A narrative review. Ther Adv Chronic Dis.
13(20406223221076890)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Efstathiou V, Stefanou MI, Demetriou M,
Siafakas N, Makris M, Tsivgoulis G, Zoumpourlis V, Kympouropoulos
SP, Tsoporis JN, Spandidos DA, et al: Long COVID and
neuropsychiatric manifestations (Review). Exp Ther Med.
23(363)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Schou TM, Joca S, Wegener G and
Bay-Richter C: Psychiatric and neuropsychiatric sequelae of
COVID-19-A systematic review. Brain Behav Immun. 97:328–348.
2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bourmistrova NW, Solomon T, Braude P,
Strawbridge R and Carter B: Long-term effects of COVID-19 on mental
health: A systematic review. J Affect Disord. 299:118–125.
2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ceban F, Ling S, Lui LMW, Lee Y, Gill H,
Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B,
et al: Fatigue and cognitive impairment in post-COVID-19 syndrome:
A systematic review and meta-analysis. Brain Behav Immun.
101:93–135. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Renaud-Charest O, Lui LMW, Eskander S,
Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y,
Subramaniapillai M and McIntyre RS: Onset and frequency of
depression in post-COVID-19 syndrome: A systematic review. J
Psychiatr Res. 144:129–137. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shanbehzadeh S, Tavahomi M, Zanjari N,
Ebrahimi-Takamjani I and Amiri-arimi S: Physical and mental health
complications post-COVID-19: Scoping review. J Psychosom Res.
147(110525)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Taquet M, Luciano S, Geddes JR and
Harrison PJ: Bidirectional associations between COVID-19 and
psychiatric disorder: Retrospective cohort studies of 62 354
COVID-19 cases in the USA. Lancet Psychiatry. 8:130–140.
2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Iosifescu AL, Hoogenboom WS, Buczek AJ,
Fleysher R and Duong TQ: New-onset and persistent neurological and
psychiatric sequelae of COVID-19 compared to influenza: A
retrospective cohort study in a large New York City healthcare
network. Int J Methods Psychiatr Res. 31(e1914)2022.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Lund LC, Hallas J, Nielsen H, Koch A,
Mogensen SH, Brun NC, Christiansen CF, Thomsen RW and Pottegård A:
Post-acute effects of SARS-CoV-2 infection in individuals not
requiring hospital admission: A Danish population-based cohort
study. Lancet Infect Dis. 21:1373–1382. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Coleman B, Casiraghi E, Blau H, Chan L,
Haendel MA, Laraway B, Callahan TJ, Deer RR, Wilkins KJ, Reese J
and Robinson PN: Risk of new-onset psychiatric sequelae of COVID-19
in the early and late post-acute phase. World Psychiatry.
21:319–320. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Taquet M, Geddes JR, Husain M, Luciano S
and Harrison PJ: 6-month neurological and psychiatric outcomes in
236 379 survivors of COVID-19: A retrospective cohort study using
electronic health records. Lancet Psychiatry. 8:416–427.
2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Abel KM, Carr MJ, Ashcroft DM, Chalder T,
Chew-Graham CA, Hope H, Kapur N, McManus S, Steeg S, Webb RT and
Pierce M: Association of SARS-CoV-2 infection with psychological
distress, psychotropic prescribing, fatigue, and sleep problems
among UK primary care patients. JAMA Netw Open.
4(e2134803)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Patel N, Dahman B and Bajaj JS:
Development of new mental and physical health sequelae among US
veterans after COVID-19. J Clin Med. 11(3390)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Chen JI, Hickok A, O'Neill AC,
Niederhausen M, Laliberte AZ, Govier DJ, Edwards ST, Gordon HS,
Slatore CG, Weaver FM, et al: Psychiatric disorders newly diagnosed
among veterans subsequent to hospitalization for COVID-19.
Psychiatry Res. 312(114570)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Clift AK, Ranger TA, Patone M, Coupland
CAC, Hatch R, Thomas K, Hippisley-Cox J and Watkinson P:
Neuropsychiatric ramifications of severe COVID-19 and other severe
acute respiratory infections. JAMA Psychiatry. 79:690–698.
2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xie Y, Xu E and Al-Aly Z: Risks of mental
health outcomes in people with covid-19: Cohort study. BMJ.
376(e068993)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Park HY, Song IA, Lee SH, Sim MY, Oh HS,
Song KH, Yu ES, Park HY and Oh TK: Prevalence of mental illness
among COVID-19 survivors in South Korea: Nationwide cohort. BJPsych
Open. 7(e183)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rivera-Izquierdo M, Láinez-Ramos-Bossini
AJ, de Alba IG, Ortiz-González-Serna R, Serrano-Ortiz Á,
Fernández-Martínez NF, Ruiz-Montero R and Cervilla JA: Long COVID
12 months after discharge: Persistent symptoms in patients
hospitalised due to COVID-19 and patients hospitalised due to other
causes-a multicentre cohort study. BMC Med. 20(92)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jacob L, Koyanagi A, Smith L, Bohlken J,
Haro JM and Kostev K: No significant association between COVID-19
diagnosis and the incidence of depression and anxiety disorder? A
retrospective cohort study conducted in Germany. J Psychiatr Res.
147:79–84. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Smith CM, Gilbert EB, Riordan PA, Helmke
N, von Isenburg M, Kincaid BR and Shirey KG: COVID-19-associated
psychosis: A systematic review of case reports. Gen Hosp
Psychiatry. 73:84–100. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Alkhamees AA: Obsessive-compulsive
disorder post-COVID-19: A case presentation. Egypt J Neurol
Psychiatr Neurosurg. 57(150)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Webster R and Holroyd S: Prevalence of
psychotic symptoms in delirium. Psychosomatics. 41:519–522.
2000.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rogers JP and David AS: A longer look at
COVID-19 and neuropsychiatric outcomes. Lancet Psychiatry.
8:351–352. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yang CP, Chang CM, Yang CC, Pariante CM
and Su KP: Long COVID and long chain fatty acids (LCFAs):
Psychoneuroimmunity implication of omega-3 LCFAs in delayed
consequences of COVID-19. Brain Behav Immun. 103:19–27.
2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Druss BG: Addressing the COVID-19 pandemic
in populations with serious mental illness. JAMA Psychiatry.
77:891–892. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Moreno C, Wykes T, Galderisi S, Nordentoft
M, Crossley N, Jones N, Cannon M, Correll CU, Byrne L, Carr S, et
al: How mental health care should change as a consequence of the
COVID-19 pandemic. Lancet Psychiatry. 7:813–824. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kola L: Global mental health and COVID-19.
Lancet Psychiatry. 7:655–657. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Gerentes M, Pelissolo A, Rajagopal K,
Tamouza R and Hamdani N: Obsessive-compulsive disorder:
Autoimmunity and neuroinflammation. Curr Psychiatry Rep.
21(78)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Maia TV, Cooney RE and Peterson BS: The
neural bases of obsessive-compulsive disorder in children and
adults. Dev Psychopathol. 20:1251–1283. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Uvais NA: Obsessive-compulsive disorder
following COVID-19 infection. Prim Care Companion CNS Disord.
23(21cr03063)2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Frick L and Pittenger C: Microglial
dysregulation in OCD, tourette syndrome and PANDAS. J Immunol Res.
2016(8606057)2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Awogbindin IO, Ben-Azu B, Olusola BA,
Akinluyi ET, Adeniyi PA, Di Paolo T and Tremblay MÈ: Microglial
implications in SARS-CoV-2 infection and COVID-19: Lessons from
viral RNA neurotropism and possible relevance to Parkinson's
disease. Front Cell Neurosci. 15(670298)2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Morgado P, Freitas D, Bessa JM, Sousa N
and Cerqueira JJ: Perceived stress in obsessive-compulsive disorder
is related with obsessive but not compulsive symptoms. Front
Psychiatry. 4(21)2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Pilotto A, Cristillo V, Cotti Piccinelli
S, Zoppi N, Bonzi G, Sattin D, Schiavolin S, Raggi A, Canale A,
Gipponi S, et al: Long-term neurological manifestations of
COVID-19: Prevalence and predictive factors. Neurol Sci.
42:4903–4907. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Park MD: Macrophages: A Trojan horse in
COVID-19? Nat Rev Immunol. 20(351)2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tizenberg BN, Brenner LA, Lowry CA,
Okusaga OO, Benavides DR, Hoisington AJ, Benros ME, Stiller JW,
Kessler RC and Postolache TT: Biological and psychological factors
determining neuropsychiatric outcomes in COVID-19. Curr Psychiatry
Rep. 23(68)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Titze-de-Almeida R, da Cunha TR, dos
Santos Silva LD, Ferreira CS, Silva CP, Ribeiro AP, de Castro
Moreira Santos Júnior A, de Paula Brandão PR, Silva APB, da Rocha
MCO, et al: Persistent, new-onset symptoms and mental health
complaints in long COVID in a Brazilian cohort of non-hospitalized
patients. BMC Infect Dis. 22(133)2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hong S, Mills PJ, Loredo JS, Adler KA and
Dimsdale JE: The association between interleukin-6, sleep and
demographic characteristics. Brain Behav Immun. 19:165–172.
2005.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Iadecola C, Anrather J and Kamel H:
Effects of COVID-19 on the nervous system. Cell. 183:16–27.e1.
2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Erickson MA and Banks WA: Neuroimmune axes
of the blood-brain barriers and blood-brain interfaces: Bases for
physiological regulation, disease states and pharmacological
interventions. Pharmacol Rev. 70:278–314. 2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Giamarellos-Bourboulis EJ, Netea MG,
Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G,
Gkavogianni T, Adami ME, Katsaounou P, et al: Complex immune
dysregulation in COVID-19 patients with severe respiratory failure.
Cell Host Microbe. 27:992–1000.e3. 2020.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Cheon SY and Koo BN: Inflammatory response
in COVID-19 patients resulting from the interaction of the
inflammasome and SARS-CoV-2. Int J Mol Sci. 22(7914)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Leisman DE, Ronner L, Pinotti R, Taylor
MD, Sinha P, Calfee CS, Hirayama AV, Mastroiani F, Turtle CJ,
Harhay MO, et al: Cytokine elevation in severe and critical
COVID-19: A rapid systematic review, meta-analysis, and comparison
with other inflammatory syndromes. Lancet Respir Med. 8:1233–1244.
2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Liu X, Zhang Z, Ruan J, Pan Y, Magupalli
VG, Wu H and Lieberman J: Inflammasome-activated gasdermin D causes
pyroptosis by forming membrane pores. Nature. 535:153–158.
2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Zhao N, Di B and Xu LL: The NLRP3
inflammasome and COVID-19: Activation, pathogenesis and therapeutic
strategies. Cytokine Growth Factor Rev. 61:2–15. 2021.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Shah P, Patel J, Soror NN and Kartan R:
Encephalopathy in COVID-19 patients. Cureus.
13(e16620)2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Moore P, Esmail F, Qin S, Nand S and Berg
S: Hypercoagulability of COVID-19 and neurological complications: A
review. J Stroke Cerebrovasc Dis. 31(106163)2022.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Helms J, Kremer S, Merdji H, Clere-Jehl R,
Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana
M, et al: Neurologic features in severe SARS-CoV-2 infection. N
Engl J Med. 382:2268–2270. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Bauer L, Laksono BM, de Vrij FMS, Kushner
SA, Harschnitz O and van Riel D: The neuroinvasiveness,
neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci.
45:358–368. 2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Ludlow M, Kortekaas J, Herden C, Hoffmann
B, Tappe D, Trebst C, Griffin DE, Brindle HE, Solomon T, Brown AS,
et al: Neurotropic virus infections as the cause of immediate and
delayed neuropathology. Acta Neuropathol. 131:159–184.
2016.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Koyuncu OO, Hogue IB and Enquist LW: Virus
infections in the nervous system. Cell Host Microbe. 13:379–393.
2013.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Fodoulian L, Tuberosa J, Rossier D,
Boillat M, Kan C, Pauli V, Egervari K, Lobrinus JA, Landis BN,
Carleton A and Rodriguez I: SARS-CoV-2 receptors and entry genes
are expressed in the human olfactory neuroepithelium and brain.
iScience. 23(101839)2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Lukiw WJ, Pogue A and Hill JM: SARS-CoV-2
infectivity and neurological targets in the brain. Cell Mol
Neurobiol. 42:217–224. 2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Jacob F, Pather SR, Huang WK, Zhang F,
Wong SZH, Zhou H, Cubitt B, Fan W, Chen CZ, Xu M, et al: Human
pluripotent stem cell-derived neural cells and brain organoids
reveal SARS-CoV-2 neurotropism predominates in choroid plexus
epithelium. Cell Stem Cell. 27:937–950.e9. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Pellegrini L, Albecka A, Mallery DL,
Kellner MJ, Paul D, Carter AP, James LC and Lancaster MA:
SARS-CoV-2 infects the brain choroid plexus and disrupts the
blood-CSF barrier in human brain organoids. Cell Stem Cell.
27:951–961.e5. 2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
McMahon CL, Staples H, Gazi M, Carrion R
and Hsieh J: SARS-CoV-2 targets glial cells in human cortical
organoids. Stem Cell Reports. 16:1156–1164. 2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Zhang BZ, Chu H, Han S, Shuai H, Deng J,
Hu YF, Gong HR, Lee AC, Zou Z, Yau T, et al: SARS-CoV-2 infects
human neural progenitor cells and brain organoids. Cell Res.
30:928–931. 2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Beristain-Covarrubias N, Perez-Toledo M,
Thomas MR, Henderson IR, Watson SP and Cunningham AF: Understanding
infection-induced thrombosis: Lessons learned from animal models.
Front Immunol. 10(2569)2019.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Goshua G, Pine AB, Meizlish ML, Chang CH,
Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, et al:
Endotheliopathy in COVID-19-associated coagulopathy: Evidence from
a single-centre, cross-sectional study. Lancet Haematol.
7:e575–e582. 2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Ramlall V, Thangaraj PM, Meydan C, Foox J,
Butler D, Kim J, May B, De Freitas JK, Glicksberg BS, Mason CE, et
al: Immune complement and coagulation dysfunction in adverse
outcomes of SARS-CoV-2 infection. Nat Med. 26:1609–1615.
2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Groff D, Sun A, Ssentongo AE, Ba DM,
Parsons N, Poudel GR, Lekoubou A, Oh JS, Ericson JE, Ssentongo P
and Chinchilli VM: Short-term and long-term rates of postacute
sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw
Open. 4(e2128568)2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Panariello A, Bassetti R, Radice A,
Rossotti R, Puoti M, Corradin M, Moreno M and Percudani M:
Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient:
A case report. Brain Behav Immun. 87:179–181. 2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Franke C, Ferse C, Kreye J, Reincke SM,
Sanchez-Sendin E, Rocco A, Steinbrenner M, Angermair S, Treskatsch
S, Zickler D, et al: High frequency of cerebrospinal fluid
autoantibodies in COVID-19 patients with neurological symptoms.
Brain Behav Immun. 93:415–419. 2021.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Mulder J, Feresiadou A, Fällmar D,
Frithiof R, Virhammar J, Rasmusson A, Rostami E, Kumlien E and
Cunningham JL: Autoimmune encephalitis presenting with malignant
catatonia in a 40-year-old male patient with COVID-19. Am J
Psychiatry. 178:485–489. 2021.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Endres D, Maier V, Leypoldt F, Wandinger
KP, Lennox B, Pollak TA, Nickel K, Maier S, Feige B, Domschke K, et
al: Autoantibody-associated psychiatric syndromes: A systematic
literature review resulting in 145 cases. Psychol Med. 52:1–12.
2020.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
|
75
|
Watson CJ, Thomas RH, Solomon T, Michael
BD, Nicholson TR and Pollak TA: COVID-19 and psychosis risk: Real
or delusional concern? Neurosci Lett. 741(135491)2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Desai AD, Lavelle M, Boursiquot BC and Wan
EY: Long-term complications of COVID-19. Am J Physiol Cell Physiol.
322:C1–C11. 2022.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Phetsouphanh C, Darley DR, Wilson DB, Howe
A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et
al: Immunological dysfunction persists for 8 months following
initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol.
23:210–216. 2022.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Farzi R, Aghbash PS, Eslami N, Azadi A,
Shamekh A, Hemmat N, Entezari-Maleki T and Baghi HB: The role of
antigen-presenting cells in the pathogenesis of COVID-19. Pathol
Res Pract. 233(153848)2022.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Spudich S and Nath A: Nervous system
consequences of COVID-19. Science. 375:267–269. 2022.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Sulzer D, Antonini A, Leta V, Nordvig A,
Smeyne RJ, Goldman JE, Al-Dalahmah O, Zecca L, Sette A, Bubacco L,
et al: COVID-19 and possible links with Parkinson's disease and
parkinsonism: From bench to bedside. NPJ Parkinsons Dis.
6(18)2020.PubMed/NCBI View Article : Google Scholar
|
